Clinical Trials Directory

Trials / Completed

CompletedNCT00001506

Evaluation and Treatment of Patients With Dermatologic Diseases

Evaluation and Treatment of Subjects With Dermatologic Diseases

Status
Completed
Phase
Study type
Observational
Enrollment
453 (actual)
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · NIH
Sex
All
Age
1 Day – 120 Years
Healthy volunteers
Not accepted

Summary

This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.

Detailed description

Background This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. This protocol was developed to allow subject enrollment for teaching purposes and to allow for second opinions regarding relatively complicated patients, and to allow for evaluation of non-invasive tools for the diagnosis and monitoring of cutaneous manifestations. This protocol promotes a critical link between the NCI, CCR Dermatology Branch and the local and national extramural medical communities. Objectives: * To provide clinical material to fulfill the educational mission of the Dermatology Branch. * To learn about the natural history of selected dermatologic diseases. Eligibility: All subjects regardless of age, gender, or racial/ethnic group with dermatologic disease or systemic disease with cutaneous manifestations. Design: Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients diagnosis, response to treatment, and/or disease progression. Non-invasive tools may be used as part of the examination and assessment of cutaneous manifestations of disease.

Conditions

Timeline

Start date
1996-08-22
Primary completion
2025-03-26
Completion
2025-04-01
First posted
1999-11-04
Last updated
2025-04-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00001506. Inclusion in this directory is not an endorsement.